Cost-effectiveness analyses of human papillomavirus vaccination
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
Cost-effectiveness analyses of human papillomavirus vaccination
AT Newall, P Beutels, JG Wood… - The Lancet Infectious …, 2007 - thelancet.com
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
[引用][C] Cost-effectiveness analyses of human papillomavirus vaccination
AT NEWALL, P BEUTELS, JG WOOD… - Lancet. Infectious …, 2007 - pascal-francis.inist.fr
Cost-effectiveness analyses of human papillomavirus vaccination CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Cost-effectiveness analyses of human papillomavirus vaccination.
AT Newall, P Beutels, JG Wood, WJ Edmunds… - 2007 - cabidigitallibrary.org
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
Cost-effectiveness analyses of human papillomavirus vaccination
AT Newall, P Beutels, JG Wood… - The Lancet …, 2007 - pubmed.ncbi.nlm.nih.gov
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
Cost-effectiveness analyses of human papillomavirus vaccination
AT Newall, P Beutels, JG Wood, WJ Edmunds… - The Lancet Infectious …, 2007 - Elsevier
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
Cost-effectiveness analyses of human papillomavirus vaccination.
AT Newall, P Beutels, JG Wood… - The Lancet …, 2007 - researchonline.lshtm.ac.uk
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
Cost-effectiveness analyses of human papillomavirus vaccination
AT Newall, P Beutels, JG Wood… - The Lancet …, 2007 - researchportal.ukhsa.gov.uk
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
[引用][C] Cost-effectiveness analyses of human papillomavirus vaccination
AT Newall, P Beutels, JG Wood… - The lancet …, 2007 - repository.uantwerpen.be
Cost-effectiveness analyses of human papillomavirus vaccination
AT Newall, P Beutels, JG Wood, WJ Edmunds… - The Lancet Infectious …, 2007 - infona.pl
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …